These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4056786)

  • 1. Penicillamine therapy for schizophreniform psychosis in Wilson's disease.
    Modai I; Karp L; Liberman UA; Munitz H
    J Nerv Ment Dis; 1985 Nov; 173(11):698-701. PubMed ID: 4056786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings.
    Krstić D; Antonijević J; Špirić Ž
    Vojnosanit Pregl; 2014 Dec; 71(12):1155-8. PubMed ID: 25639007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wilson's disease. A case history].
    Findlay D
    Can Psychiatr Assoc J; 1976 Mar; 21(2):117-21. PubMed ID: 1277094
    [No Abstract]   [Full Text] [Related]  

  • 5. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine in Wilson's disease presenting as acute liver failure with hemolysis.
    Vielhauer W; Eckardt V; Holtermüller KH; Lüth JB; Schulte B; Prellwitz W; Sonntag W
    Dig Dis Sci; 1982 Dec; 27(12):1126-9. PubMed ID: 7172963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
    Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
    J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 11. Wilson's disease: current status.
    Yarze JC; Martin P; Muñoz SJ; Friedman LS
    Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy and penicillamine treatment in a patient with Wilson's disease.
    Morimoto I; Ninomiya H; Komatsu K; Satho M
    Jpn J Med; 1986 Feb; 25(1):59-62. PubMed ID: 3712863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF copper concentration: a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation.
    Weisner B; Hartard C; Dieu C
    J Neurol Sci; 1987 Jun; 79(1-2):229-37. PubMed ID: 3612170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease--treatment of psychiatric manifestations in pregnancy.
    Rich AM; Lajoie TM
    Psychosomatics; 2012; 53(2):175-7. PubMed ID: 22424165
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
    Indaco A; Pellegrino L; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary copper excretion and hepatic copper concentrations in liver disease.
    Frommer DJ
    Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!
    Srinivas K; Sinha S; Taly AB; Prashanth LK; Arunodaya GR; Janardhana Reddy YC; Khanna S
    J Neurol Sci; 2008 Mar; 266(1-2):104-8. PubMed ID: 17904160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
    Hilz MJ; Druschky KF; Bauer J; Neundörfer B; Schuierer G
    Dtsch Med Wochenschr; 1990 Jan; 115(3):93-7. PubMed ID: 2298126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.